Pathogenesis of β2-microglobulin amyloidosis

Pathology International

Volumn 51, Issue 1, 2001, Pages 1-10

  Ohashi, Kenichi ^a  

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

Author keywords

2 microglobulin; Amyloidosis; Chondroitin sulfate; Extracellular matrix; Hemodialysis; Heparan sulfate; Matrix metalloproteinases; Proteoglycans

Indexed keywords

AMYLOID; BETA 2 MICROGLOBULIN; CHONDROITIN SULFATE; CYTOKINE; GELATINASE B; HEPARAN SULFATE; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; PERLECAN; PROTEOGLYCAN;

AMYLOIDOSIS; CLINICAL FEATURE; CYTOKINE PRODUCTION; DISEASE CLASSIFICATION; HEMODIALYSIS; HUMAN; HUMAN TISSUE; INFLAMMATION; MECHANICAL STRESS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; CERVICAL SPINE; CLASSIFICATION; INTERVERTEBRAL DISK; METABOLISM; PATHOLOGY; RENAL REPLACEMENT THERAPY;

AMYLOID; AMYLOIDOSIS; BETA 2-MICROGLOBULIN; CERVICAL VERTEBRAE; HUMANS; INTERVERTEBRAL DISK; RENAL DIALYSIS;

EID: 0034746287     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1827.2001.01156.x     Document Type: Review

References (101)

1. Zur Cellulosefrage
2. Nomenclature of amyloid and amyloidosis - WHO-IUIS Nomenclature Sub-committee
3. Amyloid arthropathy in patients undergoing periodical haemodialysis for chronic renal failure: A new complication
4. Amyloidosis of a possible new type in patients receiving long-term hemodialysis
5. Synovial amyloidosis in patients undergoing long-term hemodialysis
6. Amyloid syndromes associated with hemodialysis
7. Dialysis amyloidosis
8. Visceral involvement of dialysis amyloidosis
9. A new form of amyloid protein associated with chronic hemodialysls was identified as beta2-microglobulin
10. 2-microglobulin
11. 2-microglobulin: A new form of amyloid protein associated with chronic hemodialysis
12. 2-microglobulin occurring in human biological fluids
13. 2microglobulin
14. 2-microglobulin that is shared with other members of the immunoglobulin superfamily
15. 2-microglobulin amyloid deposition in the vertebral column
16. The basic kinematics of the human spine - A review of past and current knowledge
17. Visceral organ involvement and extracellular matrix changes in beta2-microglobulin amyloidosis - A comparative study with systemic AA and AL amyloidosis
18. 2-microglobulin amyloidosis with AA or AL amyloidosis
19. Gastrointestinal amyloid deposition in AL (primary or myeloma-associated) and AA (secondary) amyloidosis: Diagnostic value of gastric biopsy
20. Pathogenesis of amyloidosis: The two phase cellular theory of local secretion
21. Amyloidosis: A familiar problem in the light of current pathogenetic development
22. Apolipoprotein E: A pathological chaperone in patients with cerebral and systemic amyloid
23. Association of apolipoprotein E with murine amyloid A protein amyloid
24. Apolipoprotein E and alpha 1-antichymotrypsin in dialysis-related amyloidosis
25. 2-microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis
26. Three-dimensional structure of beta2-microglobulin
27. 2-microglobulin
28. Amyloid fibril protein in familial amyloidotic polyneuropathy, Portuguese type: Definition of molecular abnormality in transthyretin (prealbumin)
29. Transthyretin and apoA-I amyloidosis
30. Inherited amyloidosis
31. The 717 Val→lle substitution in amyloid precursor protein is associated with familial Alzheimer' disease regardless of ethnic groups
32. Sequencing of exons 16 and 17 of the beta-amyloid precursor protein gene in 14 families with early onset Alzheimer's disease fails to reveal mutations in the beta-amyloid sequence
33. Regulation and genetic control of brain amyloid
34. Is the formation of AL-type amyloid promoted by structural peculiarities of immunoglobulin L-chains? Primary structure of an amyloidogenic alpha-L-chain
35. Amino acid sequence of a kappaprimary (AL) amyloid protein
36. Partial amino acid sequence of an amyloid fibril protein from nodular primary cutaneous amyloidosis showing homology to lamda-immunoglobulin light chain of variable subgroup-III (A-lambda-III)
37. 2-microglobulin in the serum of hemodialysis patients and its amyloidogenic predisposition
38. 2microglobulin
39. Fractionation of primary amyloid fibrils: Characterization and chemical interaction of the subunits
40. Elastase-type proteases on the surface of human blood monocytes: Possible role in amyloid formation
41. Experimental amyloidosis: Role of the hepatocytes and Kupffer cells in amyloid formation
42. Primary structure of duck amyloid protein A: The form deposited in tissues may be identical to its serum precursor
43. Amyloid precursor protein in senile plaques of Alzheimer's disease
44. Coexistence of Alzheimer's amyloid precursor protein and amyloid protein in cerebral vessel walls
45. 2-microglobulin in amyloid deposits associated with hemodialysis
46. In vitro formation of amyloid fibrils from intact beta2-microglobulin
47. 2microglobulin in hemodialyzed patients
48. 2-microglobulin in renal disease
49. 2-microglobulin as a new form of amyloid protein in patients undergoing long-term hemodialysis
50. Tumor necrosis factor and interleukin 1: Cytokines with multiple overlapping biological activities
51. 2-microglobulin during haemodialysis
52. 2-microglobulin derived amyloidosis
53. Transfer amyloidosis
54. The induction of accelerated murine amyloid with human splenic extract: Probable role of amyloid enhancing factor
55. Evidence for increased amyloid enhancing factor activity in Alzheimer brain extract
56. Further characterization of amyloid enhancing factor
57. Enhancement of induction by amyloid fibril fragments in hamster
58. Amyloid enhancing factor-loaded macrophages in amyloid fibril formation
59. Isolation of a 16 kD fraction with extremely high AEF activity
60. New clothes for amyloid enhancing factor (AEF): Silk as AER
61. In vitro induction of hepatocyte synthesis of the acute phase reactant mouse amyloid P component by macrophages and IL I
62. Amyloid P-component is a constituent of normal human glomerular basement membrane
63. Serum amyloid P component is an acute-phase reactant in the mice
64. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein
65. Circulating amyloid P component is the precursor of amyloid P component in tissue amyloid deposits
66. Calcium-mediated hemagglutination by serum amyloid P component and the inhibition by specific glycosaminoglycans
67. Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene
68. Isolation and characterization of proteoglycans
69. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor
70. Temporal relationship between glycosaminoglycan-accumulation and amyloid deposition during experimental amyloidosis - A histochemical study
71. Induction of perlecan gene expression precedes amyloid formation during experimental murine AA amyloidogenesis
72. Heparan sulfate proteoglycans in amyloidogenesis: An epiphenomenon, a unique factor, or the tip of a more fundamental process?
73. Proteoglycans in haemodialysis-related amyloidosis
74. Glycosaminoglycans of haemodialysis-associated carpal synovial amyloid and amyloid-rich tissues and fibrils of heart, liver, and spleen
75. 2microglobulin amyloid fibrils
76. Conformation and fibrillogenesis of Alzheimer Aβ peptides with selected substitution of charged residues
77. Circular-dichroism studies on two murine serum amyloid A proteins
78. A sulfated proteoglycan aggregation factor mediates amyloid-β peptide fibril formation and neurotoxicity
79. Characterization of high affinity binding between laminin and the acute-phase protein, serum amyloid A
80. Characterization of high affinity binding between laminin and Alzheimer's disease amyloid precursor proteins
81. An interaction between basement membrane and Alzheimer amyloid precursor proteins suggests a role in the pathogenesis of Alzheimer's disease
82. High affinity interactions between the Alzheimer's beta-amyloid precursor proteins, and the basement membrane form of heparan sulphate proteoglycan
83. 2-microglobulin binding to collagen: An amyloidogenic factor in chronic haemodialysis patients
84. The heparin/heparan sulfate-binding site on apo-serum amyloid A. Implications for the therapeutic intervention of amyloidosis
85. 2-microglobulin
86. Establishment of a kinetic model of dialysis-related amyloid fibril extension in vitro
87. Apolipoprotein E phenotypes in hemodialysis patients
88. In vivo induction of interleukin-1 during hemodialysis
89. 2-microglobulin and interleukin-1 synthesis and release by mononuclear phagocytes
90. Gene expression of interleukin-1β during hemodialysis
91. Plasma levels of IL-1β, TNFα and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients
92. Aberrant cytokine production from tenosynovium in dialysis associated amyloidosis
93. 2-microglobulin modified with advanced glycation end products induces interleukin-6 from human macrophage: Role in the pathogenesis of hemodialysis-associated amyloidosis
94. 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis: Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-α and interleukin-1
95. 2-microglobulin amyloidosis
96. 2-microglobulin-like proteins
97. A new approach to dialysis amyloidosis: Intensive removal of beta2microglobulin with adsorbent column
98. Relationship between serum beta2-microglobulin, bone histology, and dialysis membranes in uremic patients
99. 2microglobulin
100. Amyloidosis associated with long-term dialysis
101. Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulfates: Implications for Alzheimer's disease